DEF 14A Filing

Company

TherapeuticsMD, Inc.

Filed

November 8, 2006

Period of Report

December 31, 2005

Accession Number

0000025743-06-000011

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →